Cue Biopharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cue Biopharma and other ETFs, options, and stocks.About CUE
Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of immunotherapies to treat cancer and autoimmune diseases. Its products include CUE-400 series (autoimmune diseases), CUE-500 series (targeted cell depletion), and CUE-100 series (Oncology).
CEOUsman Azam
CEOUsman Azam
Employees41
Employees41
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2014
Founded2014
Employees41
Employees41
CUE Key Statistics
Market cap56.70M
Market cap56.70M
Price-Earnings ratio-1.34
Price-Earnings ratio-1.34
Dividend yield—
Dividend yield—
Average volume177.43K
Average volume177.43K
High today$0.7655
High today$0.7655
Low today$0.725
Low today$0.725
Open price$0.7652
Open price$0.7652
Volume202.32K
Volume202.32K
52 Week high$1.99
52 Week high$1.99
52 Week low$0.5406
52 Week low$0.5406
People also own
Based on the portfolios of people who own CUE. This list is generated using Robinhood data, and it’s not a recommendation.